About ReShape Lifesciences
ReShape Lifesciences is a company based in Laguna Niguel (United States) founded in 2002 was acquired by EnteroMedics in October 2017. It operates as a HealthTech, and Direct-to-Consumer (D2C). ReShape Lifesciences has completed 1 acquisition, including Obalon. ReShape Lifesciences offers products and services including LAP-BAND, ReShape Vest, and ReShapeCare. ReShape Lifesciences operates in a competitive market with competitors including GI Windows, BariaTek, Hangzhou Tongee Medical Technology, ValenTx and EndObetes, among others.
- Headquarter Laguna Niguel, United States
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Reshape Lifesciences, Inc.
-
Annual Revenue
$40 K-92as on Dec 31, 2024
-
Net Profit
$-7.13 M37as on Dec 31, 2024
-
EBITDA
$-7.73 M50as on Dec 31, 2024
-
Latest Funding Round
$345.65 K (USD), Grant
Aug 20, 2024
-
Investors
HHS
& 2 more
-
Employee Count
Employee Count
- Investments & Acquisitions
-
Acquired by
EnteroMedics
(Oct 03, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ReShape Lifesciences
ReShape Lifesciences offers a comprehensive portfolio of products and services, including LAP-BAND, ReShape Vest, and ReShapeCare. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
A device for long-term weight loss treatment.
A removable device for obesity treatment support.
A service supporting obesity and metabolic treatment.
Unlock access to complete
Funding Insights of ReShape Lifesciences
- Total Funding Total Funding
- Total Rounds 12
- Last Round Grant — $345,650
-
First Round
First Round
(27 Feb 2009)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2024 | Amount | Grant - ReShape Lifesciences | Valuation |
investors |
|
| Sep, 2023 | Amount | Grant - ReShape Lifesciences | Valuation |
investors |
|
| Sep, 2022 | Amount | Grant - ReShape Lifesciences | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ReShape Lifesciences
ReShape Lifesciences has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, EnteroMedics and HealthCor Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Satiety induction through vagal nerve block
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ReShape Lifesciences
ReShape Lifesciences has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Obalon. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Gastric balloons are introduced via swallowed capsules to induce satiety.
|
2008 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - ReShape Lifesciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Reshape Lifesciences Comparisons
Competitors of ReShape Lifesciences
ReShape Lifesciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GI Windows, BariaTek, Hangzhou Tongee Medical Technology, ValenTx and EndObetes, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Nonsurgical endoscopic devices for GI tract anastomoses are developed.
|
|
| domain | founded_year | HQ Location |
Minimally invasive devices for obesity treatment are developed endoscopically.
|
|
| domain | founded_year | HQ Location |
Medical technology solutions are developed in Hangzhou, China.
|
|
| domain | founded_year | HQ Location |
Provides an adjustable endoluminal bypass sleeve for obesity treatment.
|
|
| domain | founded_year | HQ Location |
Surgical access tool for obesity and diabetes treatment is developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics and diagnostic devices for diabetes and obesity are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Reshape Lifesciences
Frequently Asked Questions about ReShape Lifesciences
When was ReShape Lifesciences founded?
ReShape Lifesciences was founded in 2002 and raised its 1st funding round 7 years after it was founded.
Where is ReShape Lifesciences located?
ReShape Lifesciences is headquartered in Laguna Niguel, United States. It is registered at Laguna Niguel, California, United States.
What is the annual revenue of ReShape Lifesciences?
Annual revenue of ReShape Lifesciences is $40K as on Dec 31, 2024.
What does ReShape Lifesciences do?
ReShape Lifesciences is engaged in developing transformative devices for obesity treatment. The company operates within the healthcare sector, specializing in medical devices and services. Solutions such as LAP-BAND and ReShape Vest are offered to address weight loss and metabolic diseases. Supportive care through programs like ReShapeCare is also provided to enhance patient outcomes.
Who are the top competitors of ReShape Lifesciences?
ReShape Lifesciences's top competitors include GI Windows, EndObetes and Hangzhou Tongee Medical Technology.
What products or services does ReShape Lifesciences offer?
ReShape Lifesciences offers LAP-BAND, ReShape Vest, and ReShapeCare.
How many acquisitions has ReShape Lifesciences made?
ReShape Lifesciences has made 1 acquisition, including Obalon.
Who are ReShape Lifesciences's investors?
ReShape Lifesciences has 3 investors. Key investors include HHS, EnteroMedics, and HealthCor Partners.